Trials / Unknown
UnknownNCT05805163
Tailored COVID-19 Testing Support Plan for Francophone African Born Immigrants
A Culturally Relevant Communication and Support Plan to Ensure Access to and Use of Covid-19 Testing for Francophone African Born Immigrants
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Texas Woman's University · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Accepted
Summary
The goal of this clinical trial is to test the effectiveness of a culturally sensitive COVID-19 testing intervention designed for Francophone (French speaking) African Born Immigrants (FABI) . The main question this study aims to answer is whether or not a a culturally sensitive COVID-19 educational pamphlet added to the home-based test will improve testing rates compared to receiving a standard home-based test alone.
Detailed description
Upon consenting, all participants will receive basic COVID-19 testing instructions from trained bilingual/bicultural Francophone African Born Immigrant (FABI) Community Health Workers (CHW's). Next, participants will be randomly assigned to either the control or intervention study arms. In the control condition (n=50) participants will receive a standard COVID-19 home-based test kit. In contrast, those assigned to the intervention condition (n=50) will receive the same COVID-19 home-based test kit plus a FABI culturally sensitive COVID-19 educational pamphlet. Lastly, (n=10) participants from each arm will be randomly selected to participate in qualitative interviews to assess their experiences with CHWs and their test kit.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | FABI tailored COVID-19 testing pamphlet | FABI adapted COVID-19 educational pamphlet |
| BEHAVIORAL | Standard COVID-19 home-based test kit | Standard COVID-19 home-based test kit |
Timeline
- Start date
- 2023-09-01
- Primary completion
- 2024-04-01
- Completion
- 2024-05-01
- First posted
- 2023-04-07
- Last updated
- 2023-04-07
Source: ClinicalTrials.gov record NCT05805163. Inclusion in this directory is not an endorsement.